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Background. Primary hyperparathyroidism (PHPT) is one of the most common endocrine conditions and is accompanied by
hypertension andincreased cardiovascular mortality. The purpose of this study was to evaluate the eﬀect ofparathyroidectomy on
systolic and diastolic blood pressure (BP) in hypertensive patients with PHPT and whether hypertension occurs more frequently
in PHPT than in control group. Methods.A total of 1020 patients with proved PHPT who underwent surgery were compared with
with 1020 age, sex, BMI, and smoking status matched controls. We evaluated changes in serum calcium, parathyroid hormone
(PTH), uric acid, and BP before and 6 months after surgery. Results. Parathyroidectomy corrected PHPT and resulted in a
s u b s t a n t i a lf a l li nb o t hm e a ns y s t o l i c( 1 5 0± 3.8 to 138 ± 3.6mmHg) and mean diastolic pressures (97 ± 3t o8 8± 2.8mmHg)of
the hypertensive subjects; P<. 01. In these patients, PTH, calcium, and uric acid normalized. 726 patients from 1020 with PHPT
(69.8%)were foundto be hypertensive whilstonly489(47.8%)from 1020ofour control group. Conclusion. Parathyroidectomyin
hypertensive patients reduces systolic and diastolic BP. PHPT is accompanied by a variety of metabolic complications, which are a
risk factor for hypertension, and parathyroidectomy can improve these metabolic complications.
1.Introduction
Primary hyperparathyroidism (PHPT) is one of the most
common endocrine conditions particularly in postmen-
opausal women. PHPT is being diagnosed with increasing
frequency mainly as a result of the introduction of routine
serum calcium measurements. This practice has also led to
ad i ﬀerent mode of presentation of PHPT. Earlier PHPT
was considered a rare illness characterized by bone disease
and urinary calculi. Many new clinical features, such as
hypertension, mental disturbances, myopathy, peptic ulcer
disease, pancreatitis, and cholelithiasis have been added to
the clinical spectrum of PHPT [1].
It has been reported that patients suﬀering from symp-
tomatic PHPT have increased mortality before and after
parathyroidectomy [2]. This increase in mortality seems to
be mainly due to an overrepresentation of cardiovascular
death[3].Hyperparathyroidismmaycoincidewithorinduce
hypertension [4].
Hypertension is common in hyperparathyroidism but
the cause of this association is not well recognized. It was
ﬁrst studied systematically by Hellstrom et al. [5]. Since
then various authors reported hypertension to be present
in between 10% and 70% of patients with primary hyper-
parathyroidism [6]. The wide variation in the prevalence
may be due to diﬀerences in methods of blood pressure
measurement, diagnostic criteria for hypertension, and
severity of hyperparathyroidism. Main sources of variability
are related to the observer, the environment, and the device.
Some studies show cure or improvement in a proportion
of patiens [7, 8] but others report no signiﬁcant changes
in blood pressure after surgery [9, 10]. The present study
is a comparison study of the blood pressures of a large
group of patients with PHPT and ofpatients receiving health2 International Journal of Endocrinology
examination at outpatients ward. We wished to determine
whether hypertension occurs more frequently in PHPT than
in control group and whether the change in blood pressure
after surgery is signiﬁcant.
2.MaterialandMethods
2.1. Study Subjects. The whole series comprise 1020 patients
(847 female and 173 males aged 20–76) with biochemically,
surgically,andhistologicallyprovedPHPTduringaperiodof
9 years (1998–2007) at Third Internal Clinic Medical School
of Charles University of Prague
The diagnosis of PHPT was conﬁrmed by histopatholog-
ical diagnosis based on combination of diﬀerent variables,
including size and histological pattern of the excised glands.
Oﬀthe1020patientswhounderwentparathyroidectomy960
had an adenoma (chiefcells) and 60 hyperplasia. Noneofthe
1020 patients with PHPT had multiple endocrine neoplasia.
Previous antihypertensive treatment was documented in
64% of all PHPT patients with hypertension. Antihyper-
tensive use in hyperparathyroid patients with hypertension
was ACE inhibitors (52%), beta blockers (24%), diuretics
25%, and calcium channel blockers (29%). All patients were
suﬀering from essential hypertension stage I or II.
The control group was drawn from 2020 patients receiv-
ing periodic health examination at outpatient ward in Third
Medical Department of Prague Charles University Medical
School from January 2004 to December 2005. The control
groupwascarefullyselectedsothateachcontrolwasmatched
with an individual patient with regard to sex, similar age,
BMI, and smoking status. The following exclusion criteria
were used: impaired renal function, malignant and sec-
ondary hypertension, and myocardial infarction. All patients
of the control group have been normocalcemic and with
normal iPTH. For comparison also were used published
data on the population prevalence awareness and control of
hypertension in the Czech population from 1985 to 2001
[11].
Study Protocol. The standardized baseline screening includ-
ed complete history, physical examination, skeletal radio-
graphs, sonography of the abdomen, electrocardiogram,
and DEXA. Serum concentrations of calcium, uric acid,
and creatinine were determined by standard laboratory
techniques in the same serum specimen in each patient.
(Technicon Autoanalyzer Roche). Normal reference values
were calcium 2.15–2.65mmol/L, creatinine 44–105umol/L,
and uric acid 140–340umol/L. The biochemical criteria for
renal functional impairment consisted of a level of serum
creatinine greater than 110umol/L. Serum intact PTH was
assayed by a two-site immunochemiluminometric assay
(Bayer Corp Chiron, Halstead UK) with mean values 1.6–
6.9pmol/L.
X-ray ﬁlms were takenof the hands, skull, and kidneys to
look for bone disease and renal calculi or nephrocalcinosis.
Also ultrasound examinations were taken of the kidneys and
gallbladder to look for calculi.
The examination consisted of a physician completed
questionnaire, which included questions of whether at any
time in the past the patient had received treatment for
high blood pressure (BP) or had hypertension diagnosed
and whether they were currently taking antihypertensive
medication. The names of currently prescribed medications
were recorded and validated against medication containers
when possible.
Heightandbody weightwere measured with participants
standing without shoes and heavy outer garments. Body
mass index (BMI) was calculated as weight divided by height
squared (kg/m2) as a measure of relative weight. Obesity was
deﬁned as BMI > 30kg/m2 for both sexes.
Smoking was classiﬁed as current, ex-(not for at least
1 year), and nonsmoker.
BP was measured three times with the patients in sitting
position following the recommendations of the current
European guidelines for blood pressure measurement. The
average of the three measurements was taken as the reference
values for each patients [12].
In this study hypertension was deﬁned as a mean systolic
BP (SBP) > 140mmHg and or a mean diastolic BP (DBP) >
90mmHg or current treatment with antihypertensive drugs.
Treatment of hypertension was deﬁned as current use of a
prescribed medication aﬀecting BP. Blood pressure in PHPT
patients and controls was measured on the right arm with
subjectinthesittingpositionafteratleast5minutesatrest by
standard mercury sphygmomanometers, and correctly sized
cuﬀsw e r eu s e d .
To withdraw antihypertensive treatment before the
examination was considered hazardous. Antihypertensive
drugs and doses were not changed throughout the study.
None of the PHPT patients complained from recent angina
pectoris, dyspnea, dizziness, or syncope.
Follow-up examinations 6 months after parathyroidec-
tomyincludedquestionnaire,physicalexamination,thesame
blood chemistries as before operation, and blood pressure
measurement.
The study was done in accordance with the principles of
the Helsinki declaration, and the procedures followed were
in accordance with institutional guidelines. The study was
approved by the Hospital ethics committee, and all patients
gave written informed consent.
Statistical and discriminant analyses of the laboratory
tests were performed by analysis of variance followed by
the multiple range test [13]. All mean values are presented
with one standard deviation (SD). A P value less than .05
(two sided test) was accepted as level of signiﬁcance. The
diﬀerence in percentages in both groups was tested using
chi-square test.The diﬀerencesbetweenthepreoperativeand
postoperativemeanvalueswere evaluatedusing thepaired or
unpaired Student’st-test.
3.Results
Parathyroidectomy corrected hyperparathyroidism in all
cases. The serum levels of calcium, iPTH and uric acid
normalized after parathyroidectomy (Table 2).
The changes of blood pressure following surgical correc-
tion of PHPT were based on blood pressure recordings 6-7
months postoperatively. The decrease in blood pressure wasInternational Journal of Endocrinology 3
Table 1: Preoperative demographic, biochemical data and BMI in patients with primary hyperparathyroidism and controls. Results are
presented as mean values ± SD. ￿P<0.01—patients with primary hyperparathyroidism versus controls.
No. Age (yrs) Gender
Female/male iPTH pmol/L Uric acid
mmol/L BMI kg/m2
Serum
creatinine
umol/L
Serum
calcium
mmol/L
All patients with PHPT 1020 58 ± 14 F: 847
M: 173 16.9 ± 2.8￿ 368 ± 45￿ 31.4 ± 2.6 74 ± 53 . 1 0 ± 0.1￿
Patients with PHPT with
hypertension.
726 59 ± 15 F: 610
M: 116 21.6 ± 4.2￿ 395 ± 58￿ 32.8 ± 2.5 93 ± 3.3 3.01 ± 0.3￿
All control patients 1020 60 ± 15 F: 847
M: 173 4.7 ± 0.6 266 ± 42 29.3 ± 3.0 71 ± 92 . 4 0 ± 0.3
Patients with hypertension
in control group.
489 61 ± 14 F: 410
M: 79 4.6 ± 1.2 290 ± 56 30.9 ± 3.2 73 ± 42 . 4 2 ± 0.2
Table 2: Preoperative and postoperative biochemical data, BMI, and arterial blood pressure in hypertensive patients with primary
hyperparathyroidism. Results are presented as mean values ± SD.
Preoperatively n = 726 Postoperatively n = 726 P value
PTH (pmol/L) 20.6 ± 8.2 5.4 ± 1.5 P<. 01
Uric acid (mmol/L) 395 ± 58 290 ± 56 P<. 01
BMI (kg/m2) 32.8 ± 2.5 33.2 ± 3.0 P>. 05
Calcium (mmol/L) 3.01 ± 0.1 2.31 ± 0.3 P<. 01
Systolic BP mmHg 150 ± 3.8 138 ± 3.6 P<. 01
Diastolic BP mmHg 97 ± 38 8 ± 2.8 P<. 01
seen not only in individuals never receiving antihypertensive
therapy but also in individuals on medication for hyperten-
sion. Parathyroidectomy resulted in a substantial fall in both
mean systolic (150 ± 3.8 to 138 ± 3.6mmHg) (P<. 01)
and mean diastolic pressures (97 ± 3t o8 8± 2.8mmHg)
(P<. 01) of the hypertensive subjects (Tables 2 and 3). We
did not observe the decrease of BP in PHPT patients without
hypertension. The mean systolic (P<. 01) and diastolic
BP (P<. 05) decreased also in hypertensive patiens on
antihypertensive therapy (Table 3).
Hypertension was documented preoperatively in 726
patients with PHPT (69.8%) whilst 294 of the patients were
normotensive. The blood pressure recorded in 726 subjects
with hypertension averaged 150 ± 3.8mmHg (systolic)
and 97.0 ± 3.0 (diastolic) in women and in men. There
were 610 women and 116 men (Table 1). In the control
group 489 patients of the entire group of 1020 patients
(47.9%) had hypertension whilst 531 of the patients were
normotensive. There were 410 women and 79 men (Table 1).
Parathyroid adenomas occurred with similar frequences in
the hypertensive and normotensive patients.
In the patients with PHPT no one had severe hyper-
tension, diastolic pressure over 120mmHg. Hypertension
appeared to be signiﬁcantly more common in the PHPT
(72.1% in the case of women and 67.4% in the case of men)
in comparison with our sex, age, BMI, and smoking status
matchedcontrolgroup(women45.9%andmen49.9%)(P<
.001).Theestimatedpercentageofhypertensive patientswith
PHPT receiving pharmacological treatment was 64.5%. It
was slightly higher in females.
There is not statistically signiﬁcant diﬀerence between
BMI of all patients with PHPT and our BMI-matched
control group (30.4 ± 2.6kg/m 2 versus 29.3 ± 3.2kg/m 2)
(P>. 05). However there is relationship between BMI and
hypertension inside the group of patients suﬀering from
PHPT. Average BMI index for women and men with PHPT
and hypertension was (32.8 ± 2.4kg/m 2) and in the present
study is higher than BMI index for women and men with
PHPT and without hypertension (29.2 ± 2.04) (P<. 01)
Table 4. Hypertension in hyperparathyroid patients was
signiﬁcantly associated with higher body mass index. After
surgery there was a signiﬁcant decrease in blood pressure
however we did not see signiﬁcant eﬀect on BMI (Table 2).
PatientswithPHPTbeforeoperationhadincreasediPTH
and serumcalciumin comparison with control subjects. Sta-
tistically signiﬁcant diﬀerences between normotensive and
hypertensivepatientswithPHPTwereevidentpreoperatively
with respect to the serum iPTH and uric acid (P<. 01)
(Table 4). PTH and calcium concentration normalized six
months after parathyroidectomy and were not diﬀerent
from controls at the follow-up visit (Table 2). Preoperative
serum calcium levels were not signiﬁcantly higher in the
hypertensive than in the normotensive patients with PHPT.
No correlation could be found between serum calcium
levels and systolic and diastolic blood pressure between
patients with PHPT and hypertension and PHPT without
hypertension before surgery. Serum uric acid levels were at
baseline signiﬁcantly higher in patients with PHPT when
compared to controls and were similar in the hypertensive
and normotensive patients with PHPT (Table 1) There were
signiﬁcant diﬀerencesinmeanserumuricacidlevelsbetween
the whole group with PHPT (368 ± 54umol/L) and the
whole control group (266 ± 49umol/L); P<. 01. Also
signiﬁcant diﬀerenceswere between the group normotensive4 International Journal of Endocrinology
Table 3: Preoperative and post-operative biochemical data, BMI and arterial blood pressure in hypertensive patients with primary
hyperparathyroidism on antihypertensive medication. Results are presented as mean values ± SD.
Preoperatively n = 663 Postoperatively n = 663 P value
PTH (pmol/L) 21.0 ± 7.2 5.6 ± 1.5 P<. 01
Uric acid (mmol/L) 344 ± 45 265 ± 46 P<. 01
BMI (kg/m2) 32.8 ± 2.5 33.1 ± 3.0 P>. 05
Calcium (mmol/L) 3.0 ± 0.1 2.31 ± 0.3 P<. 01
Systolic BP mmHg 135 ± 5.0 125 ± 3.0 P<. 01
Diastolic BP mmHg 85 ± 38 1 ± 2.8 P<. 05
Table 4: Comparisonofbiochemical data and BMI in hypertensive
patients with PHPT and normotensive patients with PHPT. Results
are presented as mean values ± SD. ￿P<. 01—patients with PHPT
andhypertension versus patients with PHPTwithouthypertension.
PHPT with
hypertension
n = 726
PHPT without
hypertension
n = 294
s.Calcium
mmol/L 3.01 ± 2.4 3.1 ± 2.04
iPTH pmol/L 21.6 ± 4.2￿ 12.2 ± 2.8
Uric acid mmol/L 395 ± 58￿ 344 ± 42
BMI kg/m2 32.8 ± 2.4￿ 29.0 ± 2.04
(344 ± 42umol/L) and hypertensive (395 ± 58umol/L)
patientswithPHPT;P<. 01.Sixmonthsafterparathyroidec-
tomy serum uric acid fell signiﬁcantly in hypertensive from
395±58 to 290±56umol/L in patientswith PHPT (P<. 01)
(Table 2).
Immunoreactive parathormone was higher in the hyper-
tensive patients with PHPT (21.6 ± 4.2pmol/L) than in the
normotensive patients with PHPT (12.2 ± 2.8pmol/L) (P<
.01) (Table 4).
Kidney involvement due either to deposition of calcium
in the renal parenchyma or to nephrolithiasis was present
in 31.4% of our patients with PHPT and only 6% in
control group. The frequency of renal calculi was similar in
patients with PHPT and hypertension (32%) and patients
withPHPTwithouthypertension(29%).Preoperativeserum
creatinine levels were statistically higher in the hypertensive
patients(93±6umol/L)than normotensive ones with PHPT
(74 ± 6umol/L) and changed in the case of hypertensive
patients signiﬁcantly after operation (71 ± 8umol/L) (P<
.01), (Table 1). The preoperative SBP was not signiﬁcantly
correlated to serum creatinine. The patients suﬀering from
chronic renal failure at the time of surgery, creatinine more
than 120umol/L were excluded from our analysis.
Adjustment for smoking status did not alter the results.
NumberofsmokingpatientswithPHPT(16.5%)was similar
to the matched control group (17.5%).
4.Discussion
In this retrospective study, we have demonstrated that
parathyroidectomy reduces blood pressure in hypertensive
patiens with PHPT. The decrease in blood pressure was seen
notonlyin individuals neverreceiving antihypertensive ther-
apy but also in individuals on medication for hypertension
indicating the pathogenetic participation of PHPT on blood
elevation.
In the present large series of patients with clinically
and biochemically proven primary hyperparathyrodism we
foundthat69.8%ofpatientshavebeensuﬀeringfromhyper-
tension. It has been suggested that arterial hypertension is
common in PHPT, and our date conﬁrm, this hypothesis.
The 69.8% prevalence of hypertension between patients
with PHPT is higher as compared with 47% prevalance
of hypertension in general population in Czech Republic
[11] and also from our sex, age, BMI control group (48%).
The mean age of all our patients with PHPT at the
time of diagnosis is 58.8 years which is almost the same
like in general population (60 years) where prevalence of
hypertension is 47% [14].
Several pathogenetic mechanisms could be responsible
f o rh i g h e rp r e v a l e n c eo fh y p e r t e n s i o ni nP H P T .S u g g e s t e d
mediators have included hypercalcemia, high PTH, plasma
renin, renal functions, uric acid, and BMI. Clinical and
experimental evidence has suggested a relation between the
serum calcium level and blood pressure. Hypercalcemia
inducedinmanbyavarietyofwaysincludingadministration
of vitamin D or abrupt intravenous infusion of calcium led
to acute elevation of blood pressure and its prompt return
to normal values when normal levels of serum calcium are
restored [15]. A close correlation has been demonstrated
between parathyroid hormone and intracellular calcium,
indicating that PTH may act as an ionophore for calcium
entry into the cells. The correction of the hyperparathyroid
condition normalizes intracellular calcium concentration
[16]. Wedidnotﬁndanycorrelationbetweenserumcalcium
level and hypertension in patients suﬀering from PHPT.
Raised concentration of parathormone can be responsi-
bleforthehypertension. PTHwashigherin ourhypertensive
patients with PHPT than in the normotensive patients
with PHPT. However fall in hormone concentrations after
surgery does not correspond to a fall in blood pressure in
all our patients. However indirect eﬀect of PTH on blood
pressure cannot be ruled out. Results of [15] suggest that
hypertension associated with clinical PHPT results from
either direct or indirect eﬀects of PTH excess. Some studies
have shown that patients with essential hypertension have
a higher serum concentration of PTH than normotensive
individuals [17].International Journal of Endocrinology 5
The administration of parathyroid hormone stimulates
the secretion of renin in dogs and in humans and is associ-
ated with an increase in plasma renin activity [18]. We have
also shown raised plasma renin activity in healthy subjects
without hypertension after administration of PTH [19].
Also the chronic elevation of parathormone in PHPT was
accompanied by high plasma renin activity. After parathy-
roidectomy plasma renin activity levels fell to normal. The
most plausible explanation may be the renal vasodilatory
eﬀect of PTH. A decrease in stretch of the aﬀerent arterioles
stimulates renin release from the juxtaglomerular apparatus
[20].
There isa possibility that hypercalcemia and/ora chronic
exposure to high PTH levels might aﬀect the arterial tone.
The patients with PHPT exhibit an impaired endothelial
vasodilatory function and parathyroidectomy can reverse
this defect [21].
Recent experimental and clinical evidence supports the
possibility that an elevated uric acid level may lead to hyper-
tension [22]. Hyperuricemia carries an increased relative
risk for hypertension developingwithin 5years, independent
of other risk factors. Both hyperuricemia and gout occur
withincreasedfrequencyinhyperparathyroidism, andPHPT
causes a reduced clearance of uric acid and raises the serum
uric levels [23]. In our patients serum uric acid was higher
in the PHPT patients than in control subjects. There were
signiﬁcant diﬀerences in mean serum uric acid level between
the group with PHPT normotensive and hypertensive. After
parathyroidectomy serum uric acid level fell signiﬁcantly in
hypertensive patients with PHPT.
PHPT is known to cause renal damage, and this might
be blamed for the raised blood pressure [24]. From our
data it does not seem very convincing that renal damage
or renal calculi are playing an important role in etiology of
hypertension in PHPT. The mean serum creatinine levels
in the hypertensive and normotensive patients with PHPT
were in normal range indicating that the hypertension of
hyperparathyroidism is not the consequence of advanced
r e n a lp a r e n c h y m a ld a m a g e .T h e r ew a sn od i ﬀerence in
the frequency of renal calculi between normotensive and
hypertensive hyperparathyroid patients.
We did not ﬁnd statistically signiﬁcant changes in BMI
between patients with PHPT and control group. However
patients with PHPT and hypertension are heavily report-
ing BMI than patients with PHPT without hypertension.
Increased body weight may contribute to the reported asso-
ciation between PHPT and hypertension. After operation
there was a signiﬁcant decrease in blood pressure; however
we did not see signiﬁcant eﬀect on BMI. Vitamin D is fat
soluble and is sequestered by adipose tissue. Thus increased
body weight may promote vitamin D deﬁciency, result-
ing in secondary hyperparathyroidism. Secondary hyper-
parathyroidism appears to increase the risk of developing
parathyroid adenoma [25]. After adjusting for smoking
status we did not observe any connection between smoking
and hypertension in our patiens with PHPT.
There is increasing evidencethat PHPTis associated with
an increased risk of cardiovascular event [26]. Patients with
PHPT have been reported to have a greater prevalence of
cardiovascular abnormalities than the normal population
[27]. Patients with PHPT seem to have an increase in mor-
tality, and this seems mainly due to an overrepresentation
of cardiovascular death. PHPT is reported to be associated
with hypertension, disturbances in the renin-angiotensin-
aldosterone system, cardiac arrhythmias as well as structural
and functional alterations in the vascular wall [28].
In conclusion PHPT is a common disorder often asso-
ciated with hypertension. Parathyroidectomy resulted in a
substantialfallinbothSBPandDBPinhypertensivepatients.
From our work it is evident that PHPT is accompanied
by a variety of metabolic complications which are a risk
factors for hypertension and that parathyroidectomy can
improve these metabolic complications. Our data support
the recommendation that parathyroidectomy should be
performed in all patients with PHPT because the procedure
stops the progression of hypertension. The present data
also reveal new possibilities in the ﬁeld of pathogenetic
mechanism of hypertension in PHPT. The present study
strengthens the view that cardiovascular derangements are
important indications for surgery in PHPT.
Our results support the hypothesis that untreated hyper-
parathyroidism is a risk factor for hypertension. Reducing
blood pressure in patients with PHPT may be beneﬁcial for
long-term cardiovascular health.
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